Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Single-use Assemblies Market Size & Growth Forecast 2027–2036, By Segments (Solution, End-use, Product, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12458| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Single-use Assemblies Market size was more than USD 17.09 billion in 2026 and is set to grow at a 15.43% CAGR between 2027 and 2036, surpassing USD 71.77 billion by 2036. The industry revenue for 2027 is assessed at USD 19.31 billion.

Base Year Value (2026)
USD 17.09 billion
CAGR (2027-2036)
15.43%
Forecast Year Value (2036)
USD 71.77 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Single-use Assemblies Market Intelligence Snapshot

Regional Market Dynamics

  • North America holds 39.42% share due to mature biopharmaceutical manufacturing, early adoption of disposable systems, and strong demand from CDMOs and large biologics producers.
  • Asia Pacific is growing at 18.37% CAGR driven by expanding biomanufacturing capacity, rapid facility buildouts, and adoption of flexible disposable systems to reduce setup time and costs.

Segment Momentum

  • Customized Solutions captured a 68.84% share in 2026 because bioprocessing facilities require assemblies tailored to specific workflows, equipment compatibility, sterility needs, and process integration while reducing contamination risks.
  • CROs & CMOs are the fastest-growing end users because single-use assemblies provide the flexibility, rapid changeovers, and modular production capabilities needed for multi-client outsourced manufacturing environments.

Market Expansion Drivers

  • Expanding biologics production driving widespread adoption of single-use bioprocessing systems.
  • Increasing biopharmaceutical R&D and CMOs accelerating disposable assembly integration.
  • Sustainable recyclable single-use systems reducing waste and improving regulatory compliance.

Leading Market Participants

  • Leading companies in the single-use assemblies market include Thermo Fisher Scientific Inc. (United States), Merck KGaA (Germany), Sartorius AG (Germany), Danaher Corporation (United States), Avantor, Inc. (United States), Lonza Group AG (Switzerland), Saint-Gobain S.A. (France), Corning Incorporated (United States), Entegris, Inc. (United States), KUHNER AG (Switzerland).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 17.09 billion
  • 2027 Estimated Market Size: USD 19.31 billion.
  • Projected Market Size: USD 71.77 billion by 2036
  • Growth Forecast: 15.43% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Customized Solutions (Solution) | Biopharmaceutical & Pharmaceutical Companies (End-use) | Filtration Assemblies (Product) | Filtration (Application)
  • Emerging Opportunity Segment: Customized Solutions (Solution) | CROs & CMOs (End-use) | Bag Assemblies (Product) | Cell Culture & Mixing (Application)
Market Dynamics

Market Growth Drivers and Industry Trends

Expanding biologics production driving widespread adoption of single-use bioprocessing systems

The rapid expansion of biologics manufacturing is increasing the need for flexible and contamination-controlled processing solutions, which will drive the single-use assemblies market growth as biopharmaceutical producers adopt disposable components across production workflows. Single-use systems can be used for fluid transfer, mixing, storage, filtration, and other bioprocessing activities without requiring extensive cleaning and sterilization between production cycles. Their use can simplify facility operations, reduce cross-contamination concerns, and support faster changeovers, making them particularly suitable for biologics manufacturing environments where production flexibility and process control are important.

Increasing biopharmaceutical R&D and CMOs accelerating disposable assembly integration

Growth in biopharmaceutical research and outsourced manufacturing is expanding the use of flexible processing infrastructure, strengthening demand in the single-use assemblies market as research organizations and contract manufacturing providers accommodate diverse production requirements. Development activities frequently involve changing processes, different product candidates, and varying batch configurations, creating demand for systems that can be deployed without extensive equipment reconfiguration. Disposable assemblies can support these operating models by reducing cleaning requirements and enabling faster setup between processes, while contract manufacturers can use standardized single-use configurations to manage multiple client programs within shared production environments.

Sustainable recyclable single-use systems reducing waste and improving regulatory compliance

The development of recyclable and more environmentally responsible disposable processing solutions is addressing sustainability concerns associated with conventional single-use manufacturing systems, supporting the single-use assemblies market as biopharmaceutical producers seek to balance operational efficiency with environmental requirements. Improvements in material selection, component design, and recycling approaches can help reduce the volume of waste associated with disposable assemblies while maintaining the contamination-control advantages expected in bioprocessing. Greater emphasis on traceability, controlled material handling, and compliance requirements is also encouraging manufacturers to adopt assembly designs that support documented processing practices and responsible disposal or recycling pathways.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Expanding biologics production driving widespread adoption of single-use bioprocessing systems 2.10% High North America, Europe High Near Term
Increasing biopharmaceutical R&D and CMOs accelerating disposable assembly integration 1.80% High Asia Pacific, North America High Near Term
Sustainable recyclable single-use systems reducing waste and improving regulatory compliance 1.50% High Europe, Asia Pacific Emerging Long Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Single-use Assemblies Market
Largest Region
North America
39.42% Market Share in 2026

North America (Largest Region)

North America accounted for the largest share of the single-use assemblies market in 2026, reaching 39.42% in 2026, driven by strong adoption of flexible bioprocessing technologies and an established pharmaceutical and biotechnology manufacturing base. Single-use assemblies are increasingly favored for applications requiring streamlined processing, reduced contamination risks, and greater operational flexibility compared with conventional reusable systems. The region's expanding focus on biologics production, process efficiency, and scalable manufacturing is supporting demand for disposable fluid-management components across biopharmaceutical workflows. Advanced manufacturing infrastructure and continued investment in life sciences are further reinforcing regional adoption.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, supported by expanding biopharmaceutical manufacturing capabilities, increasing investment in healthcare infrastructure, and growing adoption of modern processing technologies. The development of biologics and vaccine production capacity is encouraging manufacturers to implement flexible and contamination-conscious processing solutions. Increasing localization of pharmaceutical manufacturing and broader adoption of efficient bioprocessing practices are also creating significant opportunities for single-use assemblies across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Flexible Manufacturing Adoption

Germany is integrating single-use assemblies into bioprocessing facilities to support efficient production of biologics and advanced therapies. German manufacturers are emphasizing modular production strategies that require scalable and contamination-resistant fluid management systems.

France 🇫🇷

Advanced Therapy Manufacturing Support

France is increasingly using single-use assemblies in vaccine production and advanced therapy manufacturing. French bioprocessing facilities are prioritizing flexible systems that enable smaller production batches and facilitate rapid process changes without extensive downtime.

Italy 🇮🇹

Emerging Biotech Production Tools

Italy is incorporating single-use assemblies into biotechnology and pharmaceutical production environments seeking greater operational agility. Italian manufacturers are adopting disposable process components to improve efficiency while supporting specialized and smaller-scale biologic production programs.

Japan 🇯🇵

Process Efficiency Enhancement

Japan is adopting single-use assemblies to streamline biopharmaceutical manufacturing and accelerate process development activities. Companies in Japan are seeking standardized and high-quality disposable systems that reduce cleaning requirements and improve operational consistency.

South Korea 🇰🇷

Biopharma Capacity Development

South Korea's growing biopharmaceutical manufacturing sector is creating strong demand for single-use assemblies across upstream and downstream operations. Producers in South Korea are investing in disposable technologies that support rapid facility expansion and contract manufacturing activities.

United States 🇺🇸

Bioprocessing Scale Expansion

The U.S. single-use assemblies market is closely linked to expanding biologics and cell therapy manufacturing capacity. Biopharmaceutical companies in the U.S. are increasing adoption of pre-sterilized assemblies to improve production flexibility and reduce changeover requirements in multiproduct facilities.

Segment Analysis

Segment Leadership and Growth Trends

Single-use Assemblies Market Share (%), by Solution, 2026

Customized Solutions
Standard Solutions

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Solution Segment Analysis: Customized Solutions (Largest & Fastest-Growing Segment)

Customized solutions accounted for a 68.84% share of the single-use assemblies market in 2026 and represented both the largest and fastest-growing solution segment. Their strong position reflects the increasing need for single-use systems tailored to specific bioprocessing workflows, production requirements, facility configurations, and application needs. Customized assemblies can help manufacturers optimize fluid handling, reduce unnecessary connections, and improve process compatibility while supporting efficient implementation across different production environments. Growing emphasis on flexible bioprocessing, process optimization, and scalable manufacturing is strengthening demand for solutions designed around individual operational requirements.

End-use Segment Analysis: Biopharmaceutical & Pharmaceutical Companies (Largest Segment) vs CROs & CMOs (Fastest-Growing Segment)

Biopharmaceutical & pharmaceutical companies held the largest share of the single-use assemblies market at 52.42% in 2026, supported by the extensive use of disposable systems across drug development, formulation, manufacturing, and other bioprocessing activities. Single-use assemblies can reduce cleaning and sterilization requirements while helping limit contamination risks and supporting flexible production workflows. The increasing adoption of advanced biomanufacturing practices and the need for efficient production environments continue to sustain demand among pharmaceutical and biopharmaceutical manufacturers.

CROs & CMOs are expected to experience the fastest growth as outsourced research, development, and manufacturing activities become increasingly important across the biopharmaceutical industry. These organizations require adaptable processing infrastructure capable of supporting different client projects, production workflows, and batch requirements. Single-use assemblies provide operational flexibility and can facilitate faster changeovers while reducing the infrastructure burden associated with reusable systems. Rising outsourcing activity and demand for efficient, scalable manufacturing services are therefore creating strong opportunities for adoption among CROs and CMOs.

Segment Sub-Segment Largest Segment Fastest Growing
Solution Customized Solutions, Standard Solutions Customized Solutions Customized Solutions
End-use Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes Biopharmaceutical & Pharmaceutical Companies CROs & CMOs
Product Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Tubing Assemblies, Other Filtration Assemblies Bag Assemblies
Application Filtration, Cell Culture & Mixing, Storage, Sampling, Fill-finish Applications, Other Filtration Cell Culture & Mixing
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the single-use assemblies market:

1. Thermo Fisher Scientific Inc. (United States)

2. Merck KGaA (Germany)

3. Sartorius AG (Germany)

4. Danaher Corporation (United States)

5. Avantor Inc. (United States)

6. Lonza Group AG (Switzerland)

7. Saint-Gobain S.A. (France)

8. Corning Incorporated (United States)

9. Entegris Inc. (United States)

10. KUHNER AG (Switzerland)

Increasing emphasis on compliance and efficiency is shaping the single-use assemblies market. Innovation in sterile processing and modular system design is improving adaptability across production environments. The single-use assemblies market is also experiencing strong momentum in standardized solutions that support evolving operational requirements.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Thermo Fisher Scientific Inc. (United States)
Merck KGaA (Germany)
Sartorius AG (Germany)
Danaher Corporation (United States)
Avantor Inc. (United States)
Lonza Group AG (Switzerland)
Saint-Gobain S.A. (France)
Corning Incorporated (United States)
Entegris Inc. (United States)
KUHNER AG (Switzerland).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
SaniSure Apr-24 SaniSure commercialized Fill4Sure, a customized single-use filling assembly developed to improve process repeatability, security, and operational efficiency during drug fill steps.
Getinge May-23 Getinge reached a binding share-acquisition agreement to purchase Purity New England, Inc., capturing its established single-use bioprocessing technology solutions catalog.
Merck KGaA Apr-23 Merck KGaA launched Ultimus, a high-strength single-use process container film engineered for advanced leak resistance within fluid single-use assemblies.
Thermo Fisher Scientific Apr-22 Thermo Fisher Scientific established a new single-use bioprocessing manufacturing facility in Utah, USA, as part of a multi-year USD 650 million infrastructure expansion strategy.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Single-use Assemblies Market — Custom Segments

Segment Sub-Segment
Sterilization Method Gamma Irradiation, Electron Beam Irradiation, Ethylene Oxide (EtO), Autoclave
Process Scale Laboratory & Small Scale, Pilot Scale, Commercial Scale
Material Type Polyethylene (PE), Polypropylene (PP), Polyvinyl Chloride (PVC), Fluoropolymers, Other Engineering Polymers

Single-use Assemblies Market — Custom TOC

Custom Chapter Custom Details
Biopharmaceutical Manufacturing Adoption Study
  • Adoption Across Bioprocessing and Biomanufacturing Workflows
  • Single-use Requirements Across Upstream and Downstream Operations
  • Facility Scale and Process-Specific Adoption Patterns
  • Adoption Drivers Across Emerging Biopharmaceutical Modalities
  • Deployment Priorities Across New and Existing Facilities
Single-use Technology Conversion Roadmap
  • Conversion Drivers from Stainless Steel to Single-use Systems
  • Process Compatibility and Facility Integration Requirements
  • Conversion Priorities Across Bioprocessing Operations
  • Implementation Barriers and Operational Readiness
  • Scaling Pathways for Single-use Manufacturing
Contamination Control Strategy Assessment
  • Risk Reduction Across Critical Bioprocessing Operations
  • Closed-System Processing and Sterility Assurance
  • Integration with Aseptic Manufacturing Workflows
  • Process Validation and Quality Requirements
  • Emerging Contamination Control Practices

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How large is the single-use assemblies market?

In 2027 the market for single-use assemblies is worth approximately USD 19.31 billion.

What is the anticipated CAGR of the single-use assemblies industry?

Single-use Assemblies Market size was more than USD 17.09 billion in 2026 and is set to grow at a 15.43% CAGR between 2027 and 2036, surpassing USD 71.77 billion by 2036.

How is biologics manufacturing expansion influencing adoption in the single-use assemblies market?

Biologics manufacturers are standardizing single-use process systems to enable rapid changeovers, contamination control, and flexible multi-product production while reducing commissioning time and cleaning validation requirements.

Why are sustainability considerations becoming more important in single-use assemblies procurement?

Procurement is increasingly favoring recyclable, traceable assemblies that support waste management and compliance objectives while maintaining sterility and process performance in regulated bioprocessing environments.

Why do Customized Solutions dominate the single-use assemblies market?

Customized Solutions captured a 68.84% share in 2026 because bioprocessing facilities require assemblies tailored to specific workflows, equipment compatibility, sterility needs, and process integration while reducing contamination risks.

Why are CROs & CMOs the fastest-growing end users in the single-use assemblies market?

CROs & CMOs are the fastest-growing end users because single-use assemblies provide the flexibility, rapid changeovers, and modular production capabilities needed for multi-client outsourced manufacturing environments.

Why does North America lead the single-use assemblies market?

North America holds 39.42% share due to mature biopharmaceutical manufacturing, early adoption of disposable systems, and strong demand from CDMOs and large biologics producers.

What is fueling Asia Pacific growth in single-use assemblies market?

Asia Pacific is growing at 18.37% CAGR driven by expanding biomanufacturing capacity, rapid facility buildouts, and adoption of flexible disposable systems to reduce setup time and costs.

Who holds a significant market share in the single-use assemblies landscape?

Leading companies in the single-use assemblies market include Thermo Fisher Scientific Inc. (United States), Merck KGaA (Germany), Sartorius AG (Germany), Danaher Corporation (United States), Avantor, Inc. (United States), Lonza Group AG (Switzerland), Saint-Gobain S.A. (France), Corning Incorporated (United States), Entegris, Inc. (United States), KUHNER AG (Switzerland).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →